Michael ZürcherSep 4, 20232 minINSIGHTSSwitzerland’s Commitment to Healthcare as a Leader in Health Spending and Patent ApplicationSwitzerland's healthcare system is often regarded as a benchmark for high-quality healthcare, as evidenced by the country's high life...
Michael ZürcherJul 6, 20231 minSWIZZARD CHAMPIONSSwitzerland's commitment to quality in the pharmaceutical industryIn our Swizzard Champions series, we interview experienced thought leaders from the world of pharma, biotech and healthcare and share...
Michael ZürcherJun 7, 20231 minSWIZZARD CHAMPIONSWhy US Biotechs have been choosing Switzerland for over 60 years: An Interview with Jacqueline HessIn our Swizzard Champions series, Michael Zürcher, CEO of Swizzard Pharma AG, interviews Jacqueline Hess who is a business growth...
Michael ZürcherMay 11, 20232 minCOMPANY NEWSThree key takeaways from the National Council Health Commission Stakeholders in the healthcare industry will be interested in three key news items emerging from the April 26-28, 2023 meeting of the...
Michael ZürcherApr 20, 20233 minINSIGHTSArticle 71 KVV: The case-by-case approach to reimburse pharmaceuticals – a Swiss specialty1. Introduction Before a drug finds its way onto the Swiss market, permission to import must be obtained in accordance with the...
Michael ZürcherMar 8, 20231 minCOMPANY NEWSMeet Swizzard’s CEO Michael Zürcher at BIO-Europe Spring in BaselSwizzard is gearing up for BIO-Europe Spring 2023 in Basel. Mark your calendar to meet CEO @Michael Zürcher from 20-22 March 2023 at...